Evaluation of the sensitivities of six triple-negative breast cancer (TNBC) cell lines to 23 different PI3K/AKT/mTOR inhibitors or to a MEK inhibitor (trametinib). Dataset 2 of 2: GR metrics. - Dataset (ID:20365)

Data Columns

Name Description Display Name Data Type Unit Precision Readout Type Replicate Comments
r2RelCell
r^2 value for the sigmoid curve used to fit relative cell counts for treatment versus control
R-squared sigmoid fit (relative cell counts) Text
time
timepoint at which treatment response was analyzed
Timepoint Numeric hr 0